심평원 폐암 3차 적정성평가 결과
황재희2017.04.17 12:01
| 첨부파일 |
|---|
심평원 폐암 3차 적정성평가 결과
| 이전글 | '세상은 넓고, 할일은 많다' 세미나 이주원님 발표 자료 |
|---|---|
| 다음글 | 식약처 허가사항 변경 약제 |
전체 뉴스 순위
칼럼/MG툰
English News
- Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
- Samsung Biologics signs manufacturing deal with European pharmaceutical company
- Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
- ST Pharm Banwol Campus Awarded EcoVadis 'Gold' Medal
- HK inno.N-IMBiologics-Y-Biologics Transfer Autoimmune Disease Drug Tech to China
유튜브
사람들
댓글보기(0)